Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
1,105 questions in 84 reviews · Metabolic and Endocrine Disorders
current versionsNo studies 434 · 39.3%Ungraded 32 · 2.9%Very low 246 · 22.3%Low 237 · 21.4%Moderate 132 · 11.9%High 24 · 2.2%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Gastric bypass vs biliopancreatic diversion with duodenal switch (laparoscopic or open) Comorbidities: diabetes · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | 1 study · 60 participants | Very low |
Gastric bypass vs biliopancreatic diversion with duodenal switch (laparoscopic or open) Mortality · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | 2 studies · 107 participants | Moderate |
Gastric bypass vs biliopancreatic diversion with duodenal switch (laparoscopic or open) Serious adverse events (SAEs) · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Gastric bypass vs biliopancreatic diversion with duodenal switch (laparoscopic or open) Reoperations [%] · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | 2 studies · 107 participants | Very low |
Laparoscopic gastric bypass vs laparoscopic duodenojejunal bypass with sleeve gastrectomy BMI at study end [kg/m²] · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | 1 study · 57 participants | Very low |
Laparoscopic gastric bypass vs laparoscopic duodenojejunal bypass with sleeve gastrectomy Health‐related quality of life · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Laparoscopic gastric bypass vs laparoscopic duodenojejunal bypass with sleeve gastrectomy Comorbiditites: diabetes [Proportions with complete remission and partial remission] · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | 1 study · 57 participants | Very low |
Laparoscopic gastric bypass vs laparoscopic duodenojejunal bypass with sleeve gastrectomy Mortality · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | 1 study · 57 participants | Very low |
Laparoscopic gastric bypass vs laparoscopic duodenojejunal bypass with sleeve gastrectomy Serious adverse events (SAEs) · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Surgery vs no surgery Comobidities: diabetes Different definitions used · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | 5 studies · 442 participants | Moderate |
Laparoscopic gastric bypass vs laparoscopic duodenojejunal bypass with sleeve gastrectomy Reoperations [%] · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Laparoscopic adjustable gastric banding vs laparoscopic isolated sleeve gastrectomy Reduction in BMI [kg/m²] · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | 1 study · 80 participants | Very low |
Laparoscopic adjustable gastric banding vs laparoscopic isolated sleeve gastrectomy Health‐related quality of life · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Laparoscopic adjustable gastric banding vs laparoscopic isolated sleeve gastrectomy Comorbidities: diabetes · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Laparoscopic adjustable gastric banding vs laparoscopic isolated sleeve gastrectomy Mortality · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Laparoscopic adjustable gastric banding vs laparoscopic isolated sleeve gastrectomy Serious adverse events (SAEs) · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Laparoscopic adjustable gastric banding vs laparoscopic isolated sleeve gastrectomy Reoperations [%] · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | 1 study · 80 participants | Very low |
Laparaoscopic gastric imbrication vs laparoscopic sleeve gastrectomy BMI at study end [kg/m²] · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | 1 study · 30 participants | Very low |
Laparaoscopic gastric imbrication vs laparoscopic sleeve gastrectomy Health‐related quality of life · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Laparaoscopic gastric imbrication vs laparoscopic sleeve gastrectomy Comorbidities · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Surgery vs no surgery Mortality · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | 5 studies · 478 participants | Moderate |
Laparaoscopic gastric imbrication vs laparoscopic sleeve gastrectomy Mortality · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | 1 study · 30 participants | Very low |
Laparaoscopic gastric imbrication vs laparoscopic sleeve gastrectomy Serious adverse events (SAEs) · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Laparaoscopic gastric imbrication vs laparoscopic sleeve gastrectomy Reoperations [%] · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | 1 study · 30 participants | Very low |
Surgery vs no surgery Serious adverse events (SAEs) [%] · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | 4 studies · 438 participants | Very low |
Surgery vs no surgery Reoperations [%] · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | 5 studies · 470 participants | Very low |
Laparoscopic gastric bypass vs laparoscopic adjustable gastric banding BMI at study end [kg/m²] · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | 3 studies · 265 participants | Moderate |
Laparoscopic gastric bypass vs laparoscopic adjustable gastric banding Health‐related quality of life Short Form Health Survey (SF‐36) · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | 1 study · 250 participants | Very low |
Laparoscopic gastric bypass vs laparoscopic adjustable gastric banding Comorbidities:diabetes · participants with obesity Surgery for weight loss in adults (2014) · Cochrane | no estimate extracted | 1 study · 51 participants | Very low |
Intervention NR All‐cause mortality Levothyroxine or minimally invasive therapies for benign thyroid nodules (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life Levothyroxine or minimally invasive therapies for benign thyroid nodules (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse events Levothyroxine or minimally invasive therapies for benign thyroid nodules (2014) · Cochrane | RR 1.78 [0.62, 5.12] | 3 studies · 104 participants | Low |
Intervention NR Pressure symptoms / cosmetic complaints Levothyroxine or minimally invasive therapies for benign thyroid nodules (2014) · Cochrane | no estimate extracted | 3 studies · 370 participants | Low |
Intervention NR Nodule volume reduction ≥ 50% Levothyroxine or minimally invasive therapies for benign thyroid nodules (2014) · Cochrane | RR 1.83 [1.32, 2.54] | 3 studies · 105 participants | Moderate |
Intervention NR Socioeconomic effects Levothyroxine or minimally invasive therapies for benign thyroid nodules (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR All‐cause mortality Levothyroxine or minimally invasive therapies for benign thyroid nodules (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Thyroid cancer Levothyroxine or minimally invasive therapies for benign thyroid nodules (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life Levothyroxine or minimally invasive therapies for benign thyroid nodules (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse events Levothyroxine or minimally invasive therapies for benign thyroid nodules (2014) · Cochrane | no estimate extracted | 3 studies · 97 participants | Low |
Intervention NR Pressure symptoms / cosmetic complaints Levothyroxine or minimally invasive therapies for benign thyroid nodules (2014) · Cochrane | no estimate extracted | 3 studies · 92 participants | Low |
Intervention NR Thyroid cancer Levothyroxine or minimally invasive therapies for benign thyroid nodules (2014) · Cochrane | no estimate extracted | NR | Low |
Intervention NR Nodule volume reduction ≥ 50% Levothyroxine or minimally invasive therapies for benign thyroid nodules (2014) · Cochrane | no estimate extracted | 1 study · 62 participants | Low |
Intervention NR Socioeconomic effects Levothyroxine or minimally invasive therapies for benign thyroid nodules (2014) · Cochrane | no estimate extracted | 1 study · 62 participants | Low |
Intervention NR All‐cause mortality Levothyroxine or minimally invasive therapies for benign thyroid nodules (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Thyroid cancer Levothyroxine or minimally invasive therapies for benign thyroid nodules (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life Levothyroxine or minimally invasive therapies for benign thyroid nodules (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse events Levothyroxine or minimally invasive therapies for benign thyroid nodules (2014) · Cochrane | no estimate extracted | 1 study · 40 participants | Low |
Intervention NR Pressure symptoms / cosmetic complaints Levothyroxine or minimally invasive therapies for benign thyroid nodules (2014) · Cochrane | no estimate extracted | 1 study · 40 participants | Low |
Intervention NR Nodule volume reduction ≥ 50% Levothyroxine or minimally invasive therapies for benign thyroid nodules (2014) · Cochrane | no estimate extracted | 1 study · 40 participants | Low |
Intervention NR Socioeconomic effects Levothyroxine or minimally invasive therapies for benign thyroid nodules (2014) · Cochrane | no estimate extracted | NR | No studies |